No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Care Facilities
HealthCare Global Enterprises Limited (HCG), along with its subsidiaries, delivers specialized healthcare services with a primary emphasis on oncology and fertility. The company's cancer division provides comprehensive care, encompassing diagnosis and various treatment modalities such as radiation therapy, medical oncology, and surgical interventions. For fertility services, HCG operates under the Milann brand, offering a range of treatments and reproductive medicine solutions, including assisted reproduction, gynecological endoscopy, and fertility preservation. Beyond these core specializations, HCG also manages multi-specialty hospitals under its own brand. These facilities are located in Ahmedabad, Bhavnagar, and Rajkot within the state of Gujarat. Additionally, the company holds an operations and management contract for a hospital in Hubli, Karnataka, which offers diverse medical services including cardiology, neurology, orthopedics, gastroenterology, urology, internal medicine, pulmonology, and critical care. The company further extends its services to medical diagnostics, offering scientific testing and consultancy to the pharmaceutical and broader medical sectors. HealthCare Global Enterprises, founded in 1989, maintains its headquarters in Bengaluru, India, and operates numerous dedicated cancer centers.
www.hcgoncology.comNo one on the platform currently holds HCG.BO.
No tracked institution reports a position in HCG.BO as of their last filing.
No one on the platform has traded HCG.BO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 6.7% | 26.0% | — | — | — | |
| Rev. Growth % | 14.2% | 20.2% | ||||
| Profit Margin % | 0.5% | 2.1% | -1.5% | |||
| Free Cash Flow Margin % | 2.2% | 6.0% | -0.2% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $29.1B | +14.1% | $8.92 | $5.29–$10.87 | — | 8 |
| 2028 | $33.2B | +14.3% | $15.24 | $8.81–$17.52 | — | 9 |
| 2029 | $38.5B | +15.9% | $23.06 | $22.51–$24.12 | — | 3 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-06 | $2.79 | $0.95 | -65.9% |
| 2026-05-19 | $1.50 | $0.10 | -93.3% |
| 2026-02-05 | $0.73 | $0.10 | -86.5% |
| 2025-11-07 | $1.47 | $1.19 | -19.0% |
| 2025-08-01 | $0.70 | $0.40 | -42.9% |
| 2025-05-24 | $0.60 | $0.50 | -16.6% |
| 2025-02-14 | $0.55 | $0.60 | +8.4% |
| 2024-11-09 | $1.17 | $1.28 | +9.4% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| HCG.BOHealthCare Global Enterprises Limited | $677.35 | -2.35% | $102.3B | — |
| JLHL.BOJupiter Life Line Hospitals Limited | $275.40 | -1.27% | $91.9B | — |
| JLHL.NSJupiter Life Line Hospitals Limited | $275.55 | -1.29% | $90.3B | — |
| MEDPLUS.BOMedPlus Health Services Limited | $655.25 | -0.81% | $78.7B | — |
| MEDPLUS.NSMedPlus Health Services Limited |
| $656.30 |
| -0.58% |
| $78.8B |
| — |
| METROPOLIS.BOMetropolis Healthcare Limited | $572.30 | -2.25% | $119.1B | — |
| METROPOLIS.NSMetropolis Healthcare Limited | $572.50 | -2.22% | $118.7B | — |
Source: Financial Modeling Prep · peers by sector/industry